Orthofix Medical Inc. (OFIX)

Orthofix Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	83.24	33.11	50.7	87.85	96.29
Cash & Short-Term Investments	83.24	33.11	50.7	87.85	96.29
Cash Growth	151.42%	-34.70%	-42.29%	-8.77%	38.11%
Receivables	134.71	128.1	82.86	78.56	72.42
Inventory	189.45	222.17	100.15	82.97	84.64
Prepaid Expenses	23.38	32.42	22.28	20.14	16.5
Restricted Cash	2.5	4.65	-	-	0.53
Total Current Assets	433.29	420.44	255.99	269.52	270.38
Property, Plant & Equipment	157.04	178.93	65.02	62.41	68.45
Long-Term Investments	-	6.26	6.08	5.41	5
Goodwill	194.93	194.93	71.32	71.32	84.02
Other Intangible Assets	98.8	117.49	47.39	52.67	60.52
Long-Term Accounts Receivable	-	-	1.1	1.4	2
Long-Term Deferred Tax Assets	1.54	2.08	1.47	-	25.04
Long-Term Deferred Charges	1.1	1.9	0.7	1	1.4
Other Long-Term Assets	6.59	3.28	2.42	5.75	1.89
Total Assets	893.29	925.32	458.63	476.62	525.86
Accounts Payable	48.8	58.36	27.6	26.46	23.12
Accrued Expenses	98.66	93.28	49.1	49.94	48.71
Current Portion of Long-Term Debt	-	1.25	-	-	-
Current Portion of Leases	4.78	4.18	2.29	4.42	2.6
Current Unearned Revenue	-	-	-	4.79	9.83
Other Current Liabilities	16.39	8.15	4.63	20.22	19.63
Total Current Liabilities	168.63	165.22	83.62	105.83	103.9
Long-Term Debt	157.02	93.11	-	-	-
Long-Term Leases	31.92	35.66	24.62	21.33	25.28
Long-Term Unearned Revenue	-	-	-	-	4.02
Long-Term Deferred Tax Liabilities	5.64	4.17	1.26	1.08	-
Other Long-Term Liabilities	26.97	28.43	12.27	11.45	35.8
Total Liabilities	390.17	326.59	121.77	139.69	169
Common Stock	3.85	3.72	2.02	1.98	1.94
Additional Paid-In Capital	779.72	746.45	334.97	313.95	292.29
Retained Earnings	-276.14	-150.14	1.25	21	59.38
Comprehensive Income & Other	-4.3	-1.29	-1.38	-	3.25
Shareholders' Equity	503.12	598.73	336.86	336.93	356.86
Total Liabilities & Equity	893.29	925.32	458.63	476.62	525.86
Total Debt	193.71	134.2	26.91	25.76	27.89
Net Cash (Debt)	-110.47	-101.09	23.8	62.09	68.41
Net Cash Growth	-	-	-61.68%	-9.23%	59.87%
Net Cash Per Share	-2.90	-2.75	1.19	3.15	3.53
Filing Date Shares Outstanding	39.02	37.41	36.46	19.85	19.51
Total Common Shares Outstanding	38.49	37.17	20.16	19.84	19.42
Working Capital	264.66	255.22	172.37	163.69	166.48
Book Value Per Share	13.07	16.11	16.71	16.99	18.37
Tangible Book Value	209.39	286.31	218.16	212.95	212.33
Tangible Book Value Per Share	5.44	7.70	10.82	10.74	10.93
Buildings	3.87	4.1	3.87	3.93	4.1
Machinery	262.7	235.45	148.88	159.1	151.44
Construction In Progress	22.69	41.75	4.52	2.6	1.63

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q